Beacon Investment Advisory Services, Inc. Amgen Inc Transaction History

Beacon Investment Advisory Services, Inc.

$2.38 Billion
Q3 2024

A detailed history of Beacon Investment Advisory Services, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Beacon Investment Advisory Services, Inc. holds 42,439 shares of AMGN stock, worth $12.3 Million. This represents 0.57% of its overall portfolio holdings.

Number of Shares

42,439

Previous 41,693 1.79%

Holding current value

$12.3 Million

Previous $13 Million 4.97%

% of portfolio

0.57%

Previous 0.56%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$309.38 - $337.38 $230,797 - $251,685	746 Added 1.79%	42,439 $13.7 Million
Q2 2024 Aug 14, 2024	SELL	$262.75 - $319.31 $67,526 - $82,062	-257 Reduced 0.61%	41,693 $13 Million
Q1 2024 May 09, 2024	BUY	$268.87 - $324.56 $3.3 Million - $3.98 Million	12,268 Added 41.33%	41,950 $11.9 Million
Q4 2023 Feb 12, 2024	SELL	$255.7 - $288.46 $107,394 - $121,153	-420 Reduced 1.4%	29,682 $8.55 Million
Q3 2023 Oct 31, 2023	SELL	$218.65 - $271.46 $171,640 - $213,096	-785 Reduced 2.54%	30,102 $8.09 Million
Q2 2023 Jul 21, 2023	SELL	$214.27 - $253.37 $526,675 - $622,783	-2,458 Reduced 7.37%	30,887 $6.86 Million
Q1 2023 May 04, 2023	SELL	$225.79 - $275.2 $26,643 - $32,473	-118 Reduced 0.35%	33,345 $8.06 Million
Q4 2022 Jan 13, 2023	SELL	$229.03 - $291.01 $292,700 - $371,910	-1,278 Reduced 3.68%	33,463 $0
Q3 2022 Oct 20, 2022	SELL	$224.46 - $253.15 $7,182 - $8,100	-32 Reduced 0.09%	34,741 $7.83 Million
Q2 2022 Jul 21, 2022	SELL	$230.71 - $256.74 $530,863 - $590,758	-2,301 Reduced 6.21%	34,773 $8.46 Million
Q1 2022 May 12, 2022	SELL	$219.27 - $242.57 $1.08 Million - $1.2 Million	-4,931 Reduced 11.74%	37,074 $8.97 Million
Q4 2021 Feb 04, 2022	SELL	$198.88 - $227.6 $5.78 Million - $6.61 Million	-29,053 Reduced 40.89%	42,005 $9.45 Million
Q3 2021 Nov 09, 2021	SELL	$212.27 - $248.7 $4.87 Million - $5.71 Million	-22,949 Reduced 24.41%	71,058 $15.1 Million
Q2 2021 Aug 02, 2021	SELL	$233.58 - $259.14 $3.23 Million - $3.59 Million	-13,848 Reduced 12.84%	94,007 $22.9 Million
Q1 2021 May 21, 2021	SELL	$221.91 - $258.6 $797,322 - $929,149	-3,593 Reduced 3.22%	107,855 $26.8 Million
Q4 2020 Feb 08, 2021	SELL	$216.38 - $257.67 $329,979 - $392,946	-1,525 Reduced 1.35%	111,448 $25.6 Million
Q3 2020 Oct 29, 2020	SELL	$234.65 - $260.95 $203,441 - $226,243	-867 Reduced 0.76%	112,973 $28.7 Million
Q2 2020 Jul 28, 2020	BUY	$197.81 - $242.74 $207,502 - $254,634	1,049 Added 0.93%	113,840 $26.9 Million
Q1 2020 May 05, 2020	SELL	$182.24 - $241.7 $3.2 Million - $4.25 Million	-17,584 Reduced 13.49%	112,791 $22.9 Million
Q4 2019 Jan 31, 2020	BUY	$189.21 - $243.2 $13.1 Million - $16.9 Million	69,407 Added 113.84%	130,375 $31.4 Million
Q3 2019 Oct 29, 2019	BUY	$174.11 - $208.62 $543,919 - $651,728	3,124 Added 5.4%	60,968 $11.8 Million
Q2 2019 Aug 07, 2019	SELL	$166.7 - $195.41 $666,966 - $781,835	-4,001 Reduced 6.47%	57,844 $10.7 Million
Q1 2019 May 15, 2019	BUY	$180.87 - $203.88 $214,330 - $241,597	1,185 Added 1.95%	61,845 $11.7 Million
Q4 2018 Feb 08, 2019	BUY	$178.4 - $208.25 $836,517 - $976,484	4,689 Added 8.38%	60,660 $11.8 Million
Q3 2018 Nov 09, 2018	SELL	$185.29 - $208.89 $90,236 - $101,729	-487 Reduced 0.86%	55,971 $11.6 Million
Q2 2018 Aug 09, 2018	SELL	$166.05 - $186.51 $164,555 - $184,831	-991 Reduced 1.73%	56,458 $10.4 Million
Q1 2018 Apr 26, 2018	BUY	$169.43 - $198.0 $38,460 - $44,946	227 Added 0.4%	57,449 $9.79 Million
Q4 2017 Feb 02, 2018	SELL	$168.79 - $188.59 $972,567 - $1.09 Million	-5,762 Reduced 9.15%	57,222 $9.95 Million
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $10.5 Million - $12 Million	62,984	62,984 $11.7 Million

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $155B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Beacon Investment Advisory Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Beacon Investment Advisory Services, Inc. with notifications on news.

Account

Beacon Investment Advisory Services, Inc. Amgen Inc Transaction History